Hungatella sp.

Information

Microbe Identification

Hungatella sp.

Microbe id: PMDBM2021561
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Hungatella sp. [2613924]
Taxonomy Genus: Hungatella [1649459]
Taxonomy Family: n.a. [n.a.]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Hungatella sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Hungatella sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Hungatella sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Hungatella sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Hungatella sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA648014🔗2.8749158598952416S
Kidney Failure, Chronic PRJNA449784🔗3.28565797952738mNGS
Kidney Failure, Chronic PRJEB65297🔗3.50451362425436mNGS
Hypertension PRJNA509999🔗3.29539171817401mNGS
Depression, Postpartum PRJNA637228🔗2.0962566880543916S
Diabetes Mellitus, Type 2 PRJNA661673🔗3.1890113907342616S
Diarrhea PRJNA317326🔗3.6159329029289516S
Dwarfism PRJNA808649🔗-2.48102098198072mNGS
Colorectal Neoplasms PRJNA888860🔗-2.92402368781174mNGS
Colorectal Neoplasms PRJNA731589🔗2.54182720745874mNGS
Colorectal Neoplasms PRJEB53415🔗2.6665704355157316S
Colorectal Neoplasms PRJNA763023🔗2.79049306115656mNGS
Colorectal Neoplasms PRJDB11845🔗2.8588210001892716S
Colorectal Neoplasms PRJEB46665🔗3.6052243183898316S
Colorectal Neoplasms PRJNA284542🔗3.6525377656269316S
Colorectal Neoplasms PRJNA1138893🔗3.9619854077447mNGS
Acne Vulgaris PRJNA449243🔗-3.0489700683333316S
Diabetes Mellitus, Type 1 PRJNA893406🔗2.48074702235011mNGS
Parkinson Disease PRJNA588035🔗3.01210896357714mNGS
Parkinson Disease PRJNA742875🔗3.0332730144929516S
Parkinson Disease PRJNA762484🔗3.06021532484346mNGS
Colitis, Ulcerative PRJNA993675🔗2.3011603715275mNGS
Colitis, Ulcerative PRJNA398089🔗2.48649816722466mNGS
Spinal Cord Injuries PRJNA861246🔗3.5649516190047316S
Carcinoma, Renal Cell PRJNA842560🔗-2.1106973126195416S
Carcinoma, Hepatocellular PRJNA872871🔗3.1468970231397316S
Esophageal Neoplasms PRJNA698746🔗3.80750436233816S
Narcolepsy PRJEB38491🔗2.736493397178516S
Hepatolenticular Degeneration PRJNA1038771🔗3.6661060999444716S
Prediabetic State PRJNA661673🔗3.4677003162722616S
Schizophrenia PRJNA1135717🔗3.11516791093807mNGS
Asthma PRJEB59709🔗2.54444347984672mNGS
Crohn Disease PRJNA813736🔗2.14534556769421mNGS
Crohn Disease PRJEB76677🔗2.50556488064263mNGS
Crohn Disease PRJNA993675🔗3.2335232085289mNGS
Crohn Disease PRJNA398089🔗3.29751452484708mNGS
Crohn Disease PRJNA429990🔗3.57279048192324mNGS
Psoriasis PRJNA634145🔗-2.19269549304981mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗3.4211666128819316S
Cholestasis PRJNA478781🔗-3.4598061049000416S
Multiple System Atrophy PRJNA386851🔗4.7854767843913416S
Diabetic Retinopathy PRJNA857030🔗3.7460700055783716S
Arthritis, Rheumatoid PRJNA574565🔗2.861158947364616S
Fatigue Syndrome, Chronic PRJNA751448🔗2.04928490588856mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗2.9071413076206mNGS
Anorexia PRJNA674716🔗3.32565695767615mNGS
Anorexia Nervosa PRJEB38930🔗2.9727532058836816S
Neuroblastoma PRJEB63351🔗4.23981495909748mNGS
Depressive Disorder, Major PRJNA762199🔗2.89884551986962mNGS
Clostridium Infections PRJNA648321🔗4.30659338280527mNGS
Amyotrophic Lateral Sclerosis PRJEB32767🔗3.20449512542461mNGS
Liver Cirrhosis PRJNA872871🔗2.6481296240013816S
Liver Cirrhosis PRJNA861246🔗3.7777533404735516S
Cystic Fibrosis PRJNA314903🔗-3.60615010462159mNGS
Obesity PRJNA1125836🔗-3.08919317566498mNGS
HIV Infections PRJNA995875🔗-2.6237473407769616S
HIV Infections PRJNA810567🔗3.9633030974708316S
Autism Spectrum Disorder PRJNA917543🔗-3.4982070041053116S
Hand, Foot and Mouth Disease PRJNA843173🔗3.7626851365117916S
Biliary Atresia PRJNA730640🔗-2.47229532325706mNGS
Renal Insufficiency, Chronic PRJEB65297🔗3.09824137817302mNGS
Renal Insufficiency, Chronic PRJNA562327🔗3.398590687427716S
Multiple Sclerosis PRJEB53481🔗2.6491537046880216S
Multiple Sclerosis PRJNA721421🔗2.7612417990713616S
Multiple Sclerosis PRJEB28543🔗3.39632972708919mNGS
Malaria PRJNA642859🔗2.9018892577700716S
Breast Neoplasms PRJNA658160🔗2.8697361717560216S
COVID-19 PRJNA769052🔗-2.4854072952142216S
COVID-19 PRJDB13214🔗3.11739416097344mNGS
COVID-19 PRJNA624223🔗4.18441597108404mNGS
Sepsis PRJNA641414🔗2.5162653843407416S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Hungatella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Hungatella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Hungatella sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Hungatella sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Hungatella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Hungatella sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Hungatella sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Hungatella sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Hungatella sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Hungatella sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Hungatella sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?